Skip to content

R&D at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$336M-1.8%
Danaher logo
DanaherDHR
$387M+2.1%
Azenta logo
AzentaAZTA
$9.43M+24.1%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$4.06M-0.9%
TEC
Bio-TechneTECH
$23.46M-4.6%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$3.91M-0.7%

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.25B+33.1%
Enterprise value$1.24B+38.1%
P/S12.5×+0.5×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's R&D?
BioLife Solutions (BLFS) reported R&D of $2.65M in Q1 2026.
How has BioLife Solutions's R&D changed year-over-year?
BioLife Solutions's R&D increased by 84.2% year-over-year, from $1.44M to $2.65M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.